483 related articles for article (PubMed ID: 33217055)
1. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
4. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
[TBL] [Abstract][Full Text] [Related]
5. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
6. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
[TBL] [Abstract][Full Text] [Related]
7. Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.
Lee B; Young S; Williams R; Liang PS
J Med Screen; 2023 Jun; 30(2):81-86. PubMed ID: 36164282
[TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
[TBL] [Abstract][Full Text] [Related]
10. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
11. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
[TBL] [Abstract][Full Text] [Related]
12. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
13. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
14. Colorectal Cancer Screening: Is Colonoscopy the Best Option?
Liang PS; Dominitz JA
Med Clin North Am; 2019 Jan; 103(1):111-123. PubMed ID: 30466668
[TBL] [Abstract][Full Text] [Related]
15. Positive Fecal Immunochemical Test or Cologuard in the Era of the Novel Coronavirus Disease-2019 Pandemic.
Young PE; Tadros M; Mago S
Gastroenterology; 2020 Dec; 159(6):2249-2250. PubMed ID: 32450148
[No Abstract] [Full Text] [Related]
16. Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic.
Linz MO; Lorincz-Comi N; Kuwatch AA; Cooper GS
Dig Dis Sci; 2023 Dec; 68(12):4339-4349. PubMed ID: 37794293
[TBL] [Abstract][Full Text] [Related]
17. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region.
Chiu HM; Su CW; Hsu WF; Jen GH; Hsu CY; Chen SL; Chen HH
Prev Med; 2021 Oct; 151():106622. PubMed ID: 34044024
[TBL] [Abstract][Full Text] [Related]
18. Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy.
Jen HH; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Wu MS; Hsu WF; Peng SM; Chen HH; Chiu HM
J Clin Gastroenterol; 2018 Oct; 52(9):821-827. PubMed ID: 29095416
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test.
Kuipers EJ; Spaander MC
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26719226
[No Abstract] [Full Text] [Related]
20. Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic.
Levi Z; Abu-Frecha N; Comanesther D; Backenstein T; Cohen AD; Eizenstein S; Flugelman A; Weinstein O
J Med Screen; 2024 Jun; 31(2):85-90. PubMed ID: 37964557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
